Global Serum Biomarkers Market Research Report 2023

Serum biomarkers are proteins generally detected in urine, blood, and Others bodily fluids produced by malignant cells or in reaction to presence/absence of malignant cells. Preferably, biomarkers should have at least one or more than one of the following properties: prompt detection of cancer within high risk population, diagnosis of specific type of cancer, prediction in its growth, screen its treatment response, and detect early recurrence.

The global Serum Biomarkers market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

The global serum biomarkers market is projected to grow at a rapid pace in the next few years. Key drivers of the market are increase in the number of people suffering from different types of cancer and rise in the geriatric population. Increase in the cancer-afflicted population is anticipated to be anOthers key driver of the market.

This report aims to provide a comprehensive presentation of the global market for Serum Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Serum Biomarkers.

The Serum Biomarkers market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Serum Biomarkers market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Serum Biomarkers manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

1.1 Product Overview and Scope of Serum Biomarkers

1.2 Serum Biomarkers Segment by Type

1.2.1 Global Serum Biomarkers Market Value Comparison by Type (2023-2029)

1.2.2 Hepatocellular Carcinoma Serum Biomarkers

1.2.3 Lung Cancer Serum Biomarkers

1.2.4 Pancreatic & Biliary Tract Cancer Serum Biomarkers

1.2.5 Breast Cancer Serum Biomarkers

1.2.6 Glioblastoma Serum Biomarkers

1.2.7 Others

1.3 Serum Biomarkers Segment by Application

1.3.1 Global Serum Biomarkers Market Value by Application: (2023-2029)

1.3.2 Hospitals

1.3.3 Academic & Research Institutes

1.3.4 Ambulatory Surgical Centers

1.3.5 Others

1.4 Global Serum Biomarkers Market Size Estimates and Forecasts

1.4.1 Global Serum Biomarkers Revenue 2018-2029

1.4.2 Global Serum Biomarkers Sales 2018-2029

1.4.3 Global Serum Biomarkers Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Serum Biomarkers Sales Market Share by Manufacturers (2018-2023)

2.2 Global Serum Biomarkers Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Serum Biomarkers Average Price by Manufacturers (2018-2023)

2.4 Global Serum Biomarkers Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Serum Biomarkers, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Serum Biomarkers, Product Type & Application

2.7 Serum Biomarkers Market Competitive Situation and Trends

2.7.1 Serum Biomarkers Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Serum Biomarkers Players Market Share by Revenue

2.7.3 Global Serum Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Serum Biomarkers Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Serum Biomarkers Global Serum Biomarkers Sales by Region: 2018-2029

3.2.1 Global Serum Biomarkers Sales by Region: 2018-2023

3.2.2 Global Serum Biomarkers Sales by Region: 2024-2029

3.3 Global Serum Biomarkers Global Serum Biomarkers Revenue by Region: 2018-2029

3.3.1 Global Serum Biomarkers Revenue by Region: 2018-2023

3.3.2 Global Serum Biomarkers Revenue by Region: 2024-2029

3.4 North America Serum Biomarkers Market Facts & Figures by Country

3.4.1 North America Serum Biomarkers Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Serum Biomarkers Sales by Country (2018-2029)

3.4.3 North America Serum Biomarkers Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Serum Biomarkers Market Facts & Figures by Country

3.5.1 Europe Serum Biomarkers Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Serum Biomarkers Sales by Country (2018-2029)

3.5.3 Europe Serum Biomarkers Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Serum Biomarkers Market Facts & Figures by Country

3.6.1 Asia Pacific Serum Biomarkers Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Serum Biomarkers Sales by Country (2018-2029)

3.6.3 Asia Pacific Serum Biomarkers Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Serum Biomarkers Market Facts & Figures by Country

3.7.1 Latin America Serum Biomarkers Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Serum Biomarkers Sales by Country (2018-2029)

3.7.3 Latin America Serum Biomarkers Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Serum Biomarkers Market Facts & Figures by Country

3.8.1 Middle East and Africa Serum Biomarkers Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Serum Biomarkers Sales by Country (2018-2029)

3.8.3 Middle East and Africa Serum Biomarkers Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4.1 Global Serum Biomarkers Sales by Type (2018-2029)

4.1.1 Global Serum Biomarkers Sales by Type (2018-2023)

4.1.2 Global Serum Biomarkers Sales by Type (2024-2029)

4.1.3 Global Serum Biomarkers Sales Market Share by Type (2018-2029)

4.2 Global Serum Biomarkers Revenue by Type (2018-2029)

4.2.1 Global Serum Biomarkers Revenue by Type (2018-2023)

4.2.2 Global Serum Biomarkers Revenue by Type (2024-2029)

4.2.3 Global Serum Biomarkers Revenue Market Share by Type (2018-2029)

4.3 Global Serum Biomarkers Price by Type (2018-2029)

5.1 Global Serum Biomarkers Sales by Application (2018-2029)

5.1.1 Global Serum Biomarkers Sales by Application (2018-2023)

5.1.2 Global Serum Biomarkers Sales by Application (2024-2029)

5.1.3 Global Serum Biomarkers Sales Market Share by Application (2018-2029)

5.2 Global Serum Biomarkers Revenue by Application (2018-2029)

5.2.1 Global Serum Biomarkers Revenue by Application (2018-2023)

5.2.2 Global Serum Biomarkers Revenue by Application (2024-2029)

5.2.3 Global Serum Biomarkers Revenue Market Share by Application (2018-2029)

5.3 Global Serum Biomarkers Price by Application (2018-2029)

6.1 Roche

6.1.1 Roche Corporation Information

6.1.2 Roche Description and Business Overview

6.1.3 Roche Serum Biomarkers Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Roche Serum Biomarkers Product Portfolio

6.1.5 Roche Recent Developments/Updates

6.2 Pfizer

6.2.1 Pfizer Corporation Information

6.2.2 Pfizer Description and Business Overview

6.2.3 Pfizer Serum Biomarkers Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Pfizer Serum Biomarkers Product Portfolio

6.2.5 Pfizer Recent Developments/Updates

6.3 Novartis

6.3.1 Novartis Corporation Information

6.3.2 Novartis Description and Business Overview

6.3.3 Novartis Serum Biomarkers Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Novartis Serum Biomarkers Product Portfolio

6.3.5 Novartis Recent Developments/Updates

6.4 Abbott

6.4.1 Abbott Corporation Information

6.4.2 Abbott Description and Business Overview

6.4.3 Abbott Serum Biomarkers Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Abbott Serum Biomarkers Product Portfolio

6.4.5 Abbott Recent Developments/Updates

6.5 BD

6.5.1 BD Corporation Information

6.5.2 BD Description and Business Overview

6.5.3 BD Serum Biomarkers Sales, Revenue and Gross Margin (2018-2023)

6.5.4 BD Serum Biomarkers Product Portfolio

6.5.5 BD Recent Developments/Updates

6.6 Merck

6.6.1 Merck Corporation Information

6.6.2 Merck Description and Business Overview

6.6.3 Merck Serum Biomarkers Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Merck Serum Biomarkers Product Portfolio

6.6.5 Merck Recent Developments/Updates

6.7 Eli Lilly

6.6.1 Eli Lilly Corporation Information

6.6.2 Eli Lilly Description and Business Overview

6.6.3 Eli Lilly Serum Biomarkers Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Eli Lilly Serum Biomarkers Product Portfolio

6.7.5 Eli Lilly Recent Developments/Updates

6.8 Agilent Technologies

6.8.1 Agilent Technologies Corporation Information

6.8.2 Agilent Technologies Description and Business Overview

6.8.3 Agilent Technologies Serum Biomarkers Sales, Revenue and Gross Margin (2018-2023)

6.8.4 Agilent Technologies Serum Biomarkers Product Portfolio

6.8.5 Agilent Technologies Recent Developments/Updates

6.9 Boehringer Ingelheim

6.9.1 Boehringer Ingelheim Corporation Information

6.9.2 Boehringer Ingelheim Description and Business Overview

6.9.3 Boehringer Ingelheim Serum Biomarkers Sales, Revenue and Gross Margin (2018-2023)

6.9.4 Boehringer Ingelheim Serum Biomarkers Product Portfolio

6.9.5 Boehringer Ingelheim Recent Developments/Updates

6.10 AstraZeneca

6.10.1 AstraZeneca Corporation Information

6.10.2 AstraZeneca Description and Business Overview

6.10.3 AstraZeneca Serum Biomarkers Sales, Revenue and Gross Margin (2018-2023)

6.10.4 AstraZeneca Serum Biomarkers Product Portfolio

6.10.5 AstraZeneca Recent Developments/Updates

6.11 Bristol-Myers Squibb

6.11.1 Bristol-Myers Squibb Corporation Information

6.11.2 Bristol-Myers Squibb Serum Biomarkers Description and Business Overview

6.11.3 Bristol-Myers Squibb Serum Biomarkers Sales, Revenue and Gross Margin (2018-2023)

6.11.4 Bristol-Myers Squibb Serum Biomarkers Product Portfolio

6.11.5 Bristol-Myers Squibb Recent Developments/Updates

6.12 Novo Nordisk

6.12.1 Novo Nordisk Corporation Information

6.12.2 Novo Nordisk Serum Biomarkers Description and Business Overview

6.12.3 Novo Nordisk Serum Biomarkers Sales, Revenue and Gross Margin (2018-2023)

6.12.4 Novo Nordisk Serum Biomarkers Product Portfolio

6.12.5 Novo Nordisk Recent Developments/Updates

6.13 Allergan

6.13.1 Allergan Corporation Information

6.13.2 Allergan Serum Biomarkers Description and Business Overview

6.13.3 Allergan Serum Biomarkers Sales, Revenue and Gross Margin (2018-2023)

6.13.4 Allergan Serum Biomarkers Product Portfolio

6.13.5 Allergan Recent Developments/Updates

6.14 Gilead

6.14.1 Gilead Corporation Information

6.14.2 Gilead Serum Biomarkers Description and Business Overview

6.14.3 Gilead Serum Biomarkers Sales, Revenue and Gross Margin (2018-2023)

6.14.4 Gilead Serum Biomarkers Product Portfolio

6.14.5 Gilead Recent Developments/Updates

7.1 Serum Biomarkers Industry Chain Analysis

7.2 Serum Biomarkers Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Serum Biomarkers Production Mode & Process

7.4 Serum Biomarkers Sales and Marketing

7.4.1 Serum Biomarkers Sales Channels

7.4.2 Serum Biomarkers Distributors

7.5 Serum Biomarkers Customers

8.1 Serum Biomarkers Industry Trends

8.2 Serum Biomarkers Market Drivers

8.3 Serum Biomarkers Market Challenges

8.4 Serum Biomarkers Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Serum Biomarkers Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Serum Biomarkers Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Serum Biomarkers Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Serum Biomarkers Sales (K MT) of Key Manufacturers (2018-2023)

    Table 5. Global Serum Biomarkers Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Serum Biomarkers Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Serum Biomarkers Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Serum Biomarkers Average Price (USD/MT) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Serum Biomarkers, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Serum Biomarkers, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Serum Biomarkers, Product Type & Application

    Table 12. Global Key Manufacturers of Serum Biomarkers, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Serum Biomarkers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Serum Biomarkers as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Serum Biomarkers Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Serum Biomarkers Sales by Region (2018-2023) & (K MT)

    Table 18. Global Serum Biomarkers Sales Market Share by Region (2018-2023)

    Table 19. Global Serum Biomarkers Sales by Region (2024-2029) & (K MT)

    Table 20. Global Serum Biomarkers Sales Market Share by Region (2024-2029)

    Table 21. Global Serum Biomarkers Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Serum Biomarkers Revenue Market Share by Region (2018-2023)

    Table 23. Global Serum Biomarkers Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Serum Biomarkers Revenue Market Share by Region (2024-2029)

    Table 25. North America Serum Biomarkers Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Serum Biomarkers Sales by Country (2018-2023) & (K MT)

    Table 27. North America Serum Biomarkers Sales by Country (2024-2029) & (K MT)

    Table 28. North America Serum Biomarkers Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Serum Biomarkers Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Serum Biomarkers Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Serum Biomarkers Sales by Country (2018-2023) & (K MT)

    Table 32. Europe Serum Biomarkers Sales by Country (2024-2029) & (K MT)

    Table 33. Europe Serum Biomarkers Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Serum Biomarkers Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Serum Biomarkers Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Serum Biomarkers Sales by Region (2018-2023) & (K MT)

    Table 37. Asia Pacific Serum Biomarkers Sales by Region (2024-2029) & (K MT)

    Table 38. Asia Pacific Serum Biomarkers Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Serum Biomarkers Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Serum Biomarkers Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Serum Biomarkers Sales by Country (2018-2023) & (K MT)

    Table 42. Latin America Serum Biomarkers Sales by Country (2024-2029) & (K MT)

    Table 43. Latin America Serum Biomarkers Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Serum Biomarkers Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Serum Biomarkers Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Serum Biomarkers Sales by Country (2018-2023) & (K MT)

    Table 47. Middle East & Africa Serum Biomarkers Sales by Country (2024-2029) & (K MT)

    Table 48. Middle East & Africa Serum Biomarkers Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Serum Biomarkers Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Serum Biomarkers Sales (K MT) by Type (2018-2023)

    Table 51. Global Serum Biomarkers Sales (K MT) by Type (2024-2029)

    Table 52. Global Serum Biomarkers Sales Market Share by Type (2018-2023)

    Table 53. Global Serum Biomarkers Sales Market Share by Type (2024-2029)

    Table 54. Global Serum Biomarkers Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Serum Biomarkers Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Serum Biomarkers Revenue Market Share by Type (2018-2023)

    Table 57. Global Serum Biomarkers Revenue Market Share by Type (2024-2029)

    Table 58. Global Serum Biomarkers Price (USD/MT) by Type (2018-2023)

    Table 59. Global Serum Biomarkers Price (USD/MT) by Type (2024-2029)

    Table 60. Global Serum Biomarkers Sales (K MT) by Application (2018-2023)

    Table 61. Global Serum Biomarkers Sales (K MT) by Application (2024-2029)

    Table 62. Global Serum Biomarkers Sales Market Share by Application (2018-2023)

    Table 63. Global Serum Biomarkers Sales Market Share by Application (2024-2029)

    Table 64. Global Serum Biomarkers Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Serum Biomarkers Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Serum Biomarkers Revenue Market Share by Application (2018-2023)

    Table 67. Global Serum Biomarkers Revenue Market Share by Application (2024-2029)

    Table 68. Global Serum Biomarkers Price (USD/MT) by Application (2018-2023)

    Table 69. Global Serum Biomarkers Price (USD/MT) by Application (2024-2029)

    Table 70. Roche Corporation Information

    Table 71. Roche Description and Business Overview

    Table 72. Roche Serum Biomarkers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)

    Table 73. Roche Serum Biomarkers Product

    Table 74. Roche Recent Developments/Updates

    Table 75. Pfizer Corporation Information

    Table 76. Pfizer Description and Business Overview

    Table 77. Pfizer Serum Biomarkers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)

    Table 78. Pfizer Serum Biomarkers Product

    Table 79. Pfizer Recent Developments/Updates

    Table 80. Novartis Corporation Information

    Table 81. Novartis Description and Business Overview

    Table 82. Novartis Serum Biomarkers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)

    Table 83. Novartis Serum Biomarkers Product

    Table 84. Novartis Recent Developments/Updates

    Table 85. Abbott Corporation Information

    Table 86. Abbott Description and Business Overview

    Table 87. Abbott Serum Biomarkers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)

    Table 88. Abbott Serum Biomarkers Product

    Table 89. Abbott Recent Developments/Updates

    Table 90. BD Corporation Information

    Table 91. BD Description and Business Overview

    Table 92. BD Serum Biomarkers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)

    Table 93. BD Serum Biomarkers Product

    Table 94. BD Recent Developments/Updates

    Table 95. Merck Corporation Information

    Table 96. Merck Description and Business Overview

    Table 97. Merck Serum Biomarkers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)

    Table 98. Merck Serum Biomarkers Product

    Table 99. Merck Recent Developments/Updates

    Table 100. Eli Lilly Corporation Information

    Table 101. Eli Lilly Description and Business Overview

    Table 102. Eli Lilly Serum Biomarkers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)

    Table 103. Eli Lilly Serum Biomarkers Product

    Table 104. Eli Lilly Recent Developments/Updates

    Table 105. Agilent Technologies Corporation Information

    Table 106. Agilent Technologies Description and Business Overview

    Table 107. Agilent Technologies Serum Biomarkers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)

    Table 108. Agilent Technologies Serum Biomarkers Product

    Table 109. Agilent Technologies Recent Developments/Updates

    Table 110. Boehringer Ingelheim Corporation Information

    Table 111. Boehringer Ingelheim Description and Business Overview

    Table 112. Boehringer Ingelheim Serum Biomarkers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)

    Table 113. Boehringer Ingelheim Serum Biomarkers Product

    Table 114. Boehringer Ingelheim Recent Developments/Updates

    Table 115. AstraZeneca Corporation Information

    Table 116. AstraZeneca Description and Business Overview

    Table 117. AstraZeneca Serum Biomarkers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)

    Table 118. AstraZeneca Serum Biomarkers Product

    Table 119. AstraZeneca Recent Developments/Updates

    Table 120. Bristol-Myers Squibb Corporation Information

    Table 121. Bristol-Myers Squibb Description and Business Overview

    Table 122. Bristol-Myers Squibb Serum Biomarkers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)

    Table 123. Bristol-Myers Squibb Serum Biomarkers Product

    Table 124. Bristol-Myers Squibb Recent Developments/Updates

    Table 125. Novo Nordisk Corporation Information

    Table 126. Novo Nordisk Description and Business Overview

    Table 127. Novo Nordisk Serum Biomarkers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)

    Table 128. Novo Nordisk Serum Biomarkers Product

    Table 129. Novo Nordisk Recent Developments/Updates

    Table 130. Allergan Corporation Information

    Table 131. Allergan Description and Business Overview

    Table 132. Allergan Serum Biomarkers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)

    Table 133. Allergan Serum Biomarkers Product

    Table 134. Allergan Recent Developments/Updates

    Table 135. Gilead Corporation Information

    Table 136. Gilead Description and Business Overview

    Table 137. Gilead Serum Biomarkers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)

    Table 138. Gilead Serum Biomarkers Product

    Table 139. Gilead Recent Developments/Updates

    Table 140. Key Raw Materials Lists

    Table 141. Raw Materials Key Suppliers Lists

    Table 142. Serum Biomarkers Distributors List

    Table 143. Serum Biomarkers Customers List

    Table 144. Serum Biomarkers Market Trends

    Table 145. Serum Biomarkers Market Drivers

    Table 146. Serum Biomarkers Market Challenges

    Table 147. Serum Biomarkers Market Restraints

    Table 148. Research Programs/Design for This Report

    Table 149. Key Data Information from Secondary Sources

    Table 150. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Serum Biomarkers

    Figure 2. Global Serum Biomarkers Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Serum Biomarkers Market Share by Type in 2022 & 2029

    Figure 4. Hepatocellular Carcinoma Serum Biomarkers Product Picture

    Figure 5. Lung Cancer Serum Biomarkers Product Picture

    Figure 6. Pancreatic & Biliary Tract Cancer Serum Biomarkers Product Picture

    Figure 7. Breast Cancer Serum Biomarkers Product Picture

    Figure 8. Glioblastoma Serum Biomarkers Product Picture

    Figure 9. Others Product Picture

    Figure 10. Global Serum Biomarkers Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 11. Global Serum Biomarkers Market Share by Application in 2022 & 2029

    Figure 12. Hospitals

    Figure 13. Academic & Research Institutes

    Figure 14. Ambulatory Surgical Centers

    Figure 15. Others

    Figure 16. Global Serum Biomarkers Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 17. Global Serum Biomarkers Market Size (2018-2029) & (US$ Million)

    Figure 18. Global Serum Biomarkers Sales (2018-2029) & (K MT)

    Figure 19. Global Serum Biomarkers Average Price (USD/MT) & (2018-2029)

    Figure 20. Serum Biomarkers Report Years Considered

    Figure 21. Serum Biomarkers Sales Share by Manufacturers in 2022

    Figure 22. Global Serum Biomarkers Revenue Share by Manufacturers in 2022

    Figure 23. The Global 5 and 10 Largest Serum Biomarkers Players: Market Share by Revenue in 2022

    Figure 24. Serum Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 25. Global Serum Biomarkers Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 26. North America Serum Biomarkers Sales Market Share by Country (2018-2029)

    Figure 27. North America Serum Biomarkers Revenue Market Share by Country (2018-2029)

    Figure 28. U.S. Serum Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. Canada Serum Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. Europe Serum Biomarkers Sales Market Share by Country (2018-2029)

    Figure 31. Europe Serum Biomarkers Revenue Market Share by Country (2018-2029)

    Figure 32. Germany Serum Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 33. France Serum Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 34. U.K. Serum Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 35. Italy Serum Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. Russia Serum Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. Asia Pacific Serum Biomarkers Sales Market Share by Region (2018-2029)

    Figure 38. Asia Pacific Serum Biomarkers Revenue Market Share by Region (2018-2029)

    Figure 39. China Serum Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Japan Serum Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. South Korea Serum Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. India Serum Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Australia Serum Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Taiwan Serum Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Indonesia Serum Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 46. Thailand Serum Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Malaysia Serum Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Philippines Serum Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Latin America Serum Biomarkers Sales Market Share by Country (2018-2029)

    Figure 50. Latin America Serum Biomarkers Revenue Market Share by Country (2018-2029)

    Figure 51. Mexico Serum Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 52. Brazil Serum Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. Argentina Serum Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 54. Middle East & Africa Serum Biomarkers Sales Market Share by Country (2018-2029)

    Figure 55. Middle East & Africa Serum Biomarkers Revenue Market Share by Country (2018-2029)

    Figure 56. Turkey Serum Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 57. Saudi Arabia Serum Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 58. U.A.E Serum Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 59. Global Sales Market Share of Serum Biomarkers by Type (2018-2029)

    Figure 60. Global Revenue Market Share of Serum Biomarkers by Type (2018-2029)

    Figure 61. Global Serum Biomarkers Price (USD/MT) by Type (2018-2029)

    Figure 62. Global Sales Market Share of Serum Biomarkers by Application (2018-2029)

    Figure 63. Global Revenue Market Share of Serum Biomarkers by Application (2018-2029)

    Figure 64. Global Serum Biomarkers Price (USD/MT) by Application (2018-2029)

    Figure 65. Serum Biomarkers Value Chain

    Figure 66. Serum Biomarkers Production Process

    Figure 67. Channels of Distribution (Direct Vs Distribution)

    Figure 68. Distributors Profiles

    Figure 69. Bottom-up and Top-down Approaches for This Report

    Figure 70. Data Triangulation

    Figure 71. Key Executives Interviewed